Other substances

Darifenacin

An M3 muscarinic acetylcholine receptor antagonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Darifenacin on PubChem

Marketed as

DARIFENACIN; EMSELEX; ENABLEX; XELENA

 

Structure image - Darifenacin

C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5

Supporting references

Link Tested on Impact factor Notes Publication date
A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing
3CLpro Nucleocapsid protein nsp16 nsp10 Small molecule In silico 		in silico 2.74

Predicted to bind SARS-CoV-2 3C-like protease.

 Mar/18/2021
Export (.csv)